Sirion Postoperative Ocular Inflammation Candidate Durezol Shows Efficacy In Twice-Daily Dosing In Phase III Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Topical steroid has June 26 FDA action date.
You may also be interested in...
Sirion’s Durezol Cleared For Post-Op Ocular Use
The first-in-class topical steroid is set to launch in the fourth quarter.
Sirion’s Durezol Cleared For Post-Op Ocular Use
The first-in-class topical steroid is set to launch in the fourth quarter.
FDA Panel Mulls Approval Of Sirion’s Durezol
Advisory committee will consider topical ophthalmic steroid for postoperative ocular inflammation and pain on May 29.